Barrow, Hanley, Mewhinney & Strauss
AVNS

Barrow, Hanley, Mewhinney & Strauss’s Avanos Medical AVNS Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.14K Hold
438
– – ﹤0.01% 257
2025
Q4 		$4.92K Sell
438
-186
-30% -$2.13K ﹤0.01% 270
2025
Q3 		$7.21K Hold
624
– – ﹤0.01% 242
2025
Q2 		$7.64K Buy
624
+248
+66% +$3.12K ﹤0.01% 222
2025
Q1 		$5.39K Hold
376
– – ﹤0.01% 249
2024
Q4 		$5.99K Buy
376
+309
+461% +$6.12K ﹤0.01% 258
2024
Q3 		$1.61K Hold
67
– – ﹤0.01% 302
2024
Q2 		$1.33K Buy
+67
New +$1.3K ﹤0.01% 276

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's AVNS Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss held its Avanos Medical (AVNS) position steady in Q1 2026 at 438 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Barrow, Hanley, Mewhinney & Strauss first reported a position in AVNS in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.64K in Q2 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 438 shares of Avanos Medical worth $6.14K as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #257 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Avanos Medical in Q2 2024 and has held it in 8 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Avanos Medical position peaked at $7.64K in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.